Effect of β-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats

Chest

Volumn 128, Issue 3, 2005, Pages 1812-1821

  Sun, Yi Lan ^a   Hu, Shen Jiang ^a   Wang, Li Hong ^a   Hu, Ying ^a   Zhou, Jian Ying ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Ca2+ adenosine triphosphatase; Carvedilol; Heart failure; Metoprolol; Phospholamban; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; MESSENGER RNA; METOPROLOL; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM ADENOSINE TRIPHOSPHATASE (CALCIUM); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE; HEART WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 24944504337     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.3.1812     Document Type: Article

References (31)

1. Bristow MR. β-Adrenergic receptor blockade in chronic heart failure. Circulation 2000; 101:558-569
2. Plank DM, Yatani A, Ritsu H, et al. Calcium dynamics in the failing heart: restoration by β-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol 2003; 285:H305-H315
3. Meyer M, Schillinger W, Pieske B, et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995; 92:778-784
4. Hasenfuss G, Reinecke H, Studer R, et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 1994; 75:434-442
5. Schwinger RH, Bohm M, Schmidt U, et al. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995; 92:3220-3228
6. Kubo H, Margulies KB, Piacentino V 3rd, et al. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001; 104: 1012-1018
7. Lennon NJ, O'Reilly C, Ohlendieck K. Impaired Ca2+-ATPase oligomerization and increased phospholamban expression in dilated cardiomyopathy. Int J Mol Med 2000; 6:533-538
8. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993; 342:1441-1446
9. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation 1994; 90:1765-1773
10. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334:1349-1355
11. Wei S, Chow LT, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 2000; 36:276-281
12. Masson S, Masseroli M, Fiordaliso F, et al. Effects of a DA2/α2 agonist and a β1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion. J Cardiovasc Pharmacol 1999; 34:321-326
13. Pfeffer JM, Finn PV, Zornoff LA, et al. Endothelin-A receptor antagonism during acute myocardial infarction in rats. Cardiovasc Drugs Ther 2000; 14:579-587
14. Fruebis J, Gonzalez V, Silvestre M, et al. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol 1997; 17:1289-1302
15. Mirit E, Palmon A, Hasin Y, et al. Heat acclimation induces changes in cardiac mechanical performance: the role of thyroid hormone. Am J Physiol 1999; 276:R550-R558
16. Metra M, Nodari S, D'Aloia A et al. A rationale for the use of β-blockers as standard treatment for heart failure. Am Heart J 2000; 139:511-521
17. Litwin SE, Katz SE, Morgan JP, et al. Long-term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction. J Am Coll Cardiol 1996; 28:773-781
18. Senior R, Basu S, Kinsey C, et al. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction. Am Heart J 1999; 137:646-652
19. Capomolla S, Febo O, Gnemmi M, et al. β-Blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139: 596-608
20. Aoyagi T, Yonekura K, Eto Y, et al. The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts. J Mol Cell Cardiol 1999; 31:919-926
21. Zanchetti A, Stella A. Neural control of renin release. Clin Sci Mol Med Suppl 1975; 2:215s-223s
22. Eichhorn EJ, Heesch CM, Risser RC, et al. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol 1995; 25:154-162
23. Flesch M, Maack C, Cremers B, et al. Effect of beta-blockers on tree radical-induced cardiac contractile dysfunction. Circulation 1999; 100:346-353
24. Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation 2000; 101:790-796
25. Ito K, Yan X, Feng X, et al. Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure. Circ Res 2001; 89:422-449
26. Stein B, Bartel S, Kokott S, et al. Effects of isoprenaline on force of contraction, cAMP content, and phosphorylation of regulatory proteins in hearts from chronic beta-adrenergic-stimulated rats. Ann N Y Acad Sci 1995; 752:230-233
27. Netticadan T, Temsah RM, Kawabata K, et al. Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res 2000; 86:596-605
28. Zaugg M, Xu W, Lucchinetti E, et al. β-Adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000; 102:344-350
29. Kubo H, Margulies KB, Piacentino V 3rd, et al. Patients with end-stage congestive heart failure treated with β-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001; 104: 1012-1018
30. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996; 94:2807-2816
31. Watanabe K, Ohta Y, Nakazawa M, et al. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 2000; 130:1489-1495